Pubblicazioni

  • HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b (under review)
  • Which is the real efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in HCV infected patients with advanced fibrosis ? J Hepatol. 2012 Apr 14. [Epub ahead of print] PubMed PMID: 22510262.
  • Hepatitis C virus-related B cell subtypes in non Hodgkin’s lymphoma World J Hepatol 2011 November 27; 3(11): 278-284 ISSN 1948-5182 (online)© 2011
  •  Rapid virological response as predictor of sustained response in HCV carriers with persistently normal alanine aminotransferase levels. A multicentric study. J Viral Hepat. 2010 Jun 8. [Epub ahead of print]
  • Comparison of peginterferon alfa-2a and ribavirin for 12 or 24 weeks in patients with HCV genotype 2 or 3: the CLEO trial. BMC Gastrenterology 2010 Feb 19;10(1):21. [Epub ahead of print] PMID: 20170514 [PubMed – as supplied by publisher]
  • Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study. Liver Int. 2009 Nov;29(10):1479-84. Epub 2009 Apr 28. PMID: 19422478 [PubMed – in process]
  • Adefovir and Lamivudine in combination compared to Adefovir alone in HBeAg-negative chronic Hepatitis  B patients wiyh clinical resistance to Lamivudine: a multicenter retrospective study. Clin Ther. 2008 Feb;30(2):317-23.PMID: 18343270 [PubMed – indexed for MEDLINE]
  • Management of chronic hepatitis in drug addicts: a systematic review. Clin Ter. 2008 Jan-Feb;159(1):41-9. Review.PMID: 18399262 [PubMed – indexed for MEDLINE]
  • 1980 2015 HCV preval incid
  • long term pellicelli hbv 2014
  • WJH-CLEO 2016

I commenti sono chiusi